BioHarvest Sciences Past Earnings Performance
Past criteria checks 0/6
BioHarvest Sciences's earnings have been declining at an average annual rate of -20.7%, while the Personal Products industry saw earnings growing at 3.2% annually. Revenues have been growing at an average rate of 82.6% per year.
Key information
-20.7%
Earnings growth rate
64.6%
EPS growth rate
| Personal Products Industry Growth | 8.7% |
| Revenue growth rate | 82.6% |
| Return on equity | n/a |
| Net Margin | -116.0% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How BioHarvest Sciences makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 16 | -18 | 13 | 4 |
| 31 Dec 23 | 13 | -13 | 12 | 3 |
| 30 Sep 23 | 11 | -8 | 11 | 3 |
| 30 Jun 23 | 9 | -10 | 11 | 3 |
| 31 Mar 23 | 7 | -10 | 10 | 2 |
| 31 Dec 22 | 5 | -11 | 10 | 2 |
| 30 Sep 22 | 4 | -10 | 6 | 4 |
| 30 Jun 22 | 3 | -9 | 6 | 4 |
| 31 Mar 22 | 2 | -5 | 5 | 4 |
| 31 Dec 21 | 2 | -10 | 5 | 4 |
| 30 Sep 21 | 2 | -11 | 8 | 3 |
| 30 Jun 21 | 1 | -10 | 7 | 2 |
| 31 Mar 21 | 1 | -13 | 6 | 2 |
| 31 Dec 20 | 0 | -7 | 4 | 1 |
| 30 Sep 20 | 0 | -5 | 3 | 1 |
| 30 Jun 20 | 0 | -5 | 2 | 1 |
| 31 Mar 20 | 0 | -4 | 1 | 1 |
| 31 Dec 19 | 0 | -5 | 1 | 1 |
| 30 Sep 19 | 0 | -5 | 1 | 1 |
| 31 Dec 18 | 0 | -7 | 1 | 1 |
| 31 Dec 17 | 0 | -2 | 1 | 0 |
| 31 Dec 16 | 0 | -3 | 2 | 0 |
Quality Earnings: 8MV0 is currently unprofitable.
Growing Profit Margin: 8MV0 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 8MV0 is unprofitable, and losses have increased over the past 5 years at a rate of 20.7% per year.
Accelerating Growth: Unable to compare 8MV0's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 8MV0 is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (16.6%).
Return on Equity
High ROE: 8MV0's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.